U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on Monday.
Shares of Alcoa Corporation (NYSE:AA) rose sharply during Monday's session after the company agreed to sell its 25.1% joint venture stake in Ma’aden for $1.1 billion, including $950 million in Ma’aden shares.
Alcoa shares jumped 6.5% to $34.63 on Monday.
Here are some other big stocks recording gains in today's session.
- Ascendis Pharma A/S (NASDAQ:ASND) shares jumped 19.8% to $142.76 after the company announced topline data from its pivotal approach trial of Transcon CNP (Navepegritide).
- Bausch + Lomb Corporation (NASDAQ:BLCO) shares gained 15% to $17.86. Needham reiterated a Hold rating on Bausch & Lomb.
- Nuvalent, Inc. (NASDAQ:NUVL) climbed 12.8% to $98.70 after the company highlighted results for its ROS1 and ALK-Positive NSCLC programs and accelerated its development timeline. Also, the company announced a $350 million public offering and multiple firms raised their respective price targets on the stock.
- Fitell Corporation (NASDAQ:FTEL) gained 12.5% to $17.75.
- JBDI Holdings Limited (NASDAQ:JBDI) jumped 11.1% to $29.38.
- Lattice Semiconductor Corporation (NASDAQ:LSCC) surged 10.3% to $49.46. Lattice Semiconductor appointed Ford Tamer as CEO, effective immediately.
- EchoStar Corporation (NASDAQ:SATS) rose 8.4% to $26.33. Morgan Stanley, on Friday, raised its price target on the stock from $14 to $20.
- Stratasys Ltd. (NASDAQ:SSYS) rose 7.9% to $7.61 after the company authorized a share repurchase program of up to $50 million.
- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) gained 7.5% to $5.48. The announced it initiated the registrational Phase 3 clinical trial of Soquelitinib for patients with relapsed or refractory peripheral T-cell lymphoma.
- Viasat, Inc. (NASDAQ:VSAT) rose 6.3% to $13.57.
- Hertz Global Holdings, Inc. (NASDAQ:HTZ) rose 5.5% to $3.1650.
- Sprouts Farmers Market, Inc. (NASDAQ:SFM) gained 4.2% to $106.42. Evercore ISI Group analyst Michael Morris upgraded Sprouts Farmers Market from In-Line to Outperform and raised the price target from $96 to $120.
Now Read This: